← Scoopfeeds — Intelligent news, curated.
Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock
business

Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock

Investing.com · Jul 1, 2026, 8:22 PM · Also reported by 1 other source

Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock

Read full story on Investing.com → More top stories

Also covered by

Yahoo Finance Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?

More in business

Forbes
Mitch McConnell Was Reportedly Found Unconscious Last Month—What We Know About His Health
Investing.com
BofA raises argenx stock price target to $1,088 on myositis data
Investing.com
Applied materials CEO Gary Dickerson’s $55.5m stock sales
Investing.com
American well chief product & tech. officer sells $78,931 in stock
Investing.com
Form 4 Cogent Communications Holdings Inc For: 1 July
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop